Gene therapy for chronic myocardial ischemia using platelet-derived endothelial cell growth factor in dogs.
about
Thymidine Phosphorylase Participates in Platelet Signaling and Promotes ThrombosisSPECT and PET imaging of angiogenesis and arteriogenesis in pre-clinical models of myocardial ischemia and peripheral vascular diseaseAngiogenic biomarkers in children with congenital heart disease: possible implications.Preventing local regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 enhances angiogenesis.Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3Ligation of the left circumflex coronary artery with subsequent MRI and histopathology in rabbits.The Hedgehog transcription factor Gli3 modulates angiogenesis.Modification of infarct material properties limits adverse ventricular remodeling.Antiangiogenic and antitumor activity of 6-(2-aminoethyl)amino-5-chlorouracil, a novel small-molecule inhibitor of thymidine phosphorylase, in combination with the vascular endothelial growth factor-trap.Conditional expression of the type 2 angiotensin II receptor in mesenchymal stem cells inhibits neointimal formation after arterial injury.Angiogenic growth factors in myocardial infarction: a critical appraisal.Platelet-derived endothelial cell growth factor mediates angiogenesis and antiapoptosis in rat aortic endothelial cells.Thymidine phosphorylase: A potential new target for treating cardiovascular disease.Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep.
P2860
Q27339642-06C32CCD-92EC-4163-A01D-62E285E97B59Q28066121-9E513ABA-9AAC-4AFD-A525-05742F778F1BQ33869129-6B2A04C4-CD04-44F8-8D74-C24340A965ABQ33922773-B133E9A8-A252-4C91-8310-98951A08EA19Q34046503-D3D2467F-B09E-4D7F-AF42-DA41FDA56FA5Q34362493-0A30E76A-6C7C-4AB0-86FE-73BB62C7FB78Q35219195-00EA8D09-B2E6-413F-9BB6-3E076A8A4138Q35662201-7902499B-9C45-48B8-ADD0-631D75E66933Q37421793-63DE657D-CFAC-4902-9B8E-B94D4EA7D8EDQ38966432-B2FEB3B9-882D-4D06-82CA-1A5137F8B706Q39389842-E0527CF4-AB4A-44BE-8D71-2B699D8C2AD0Q43236364-CE28E079-AFC6-47C0-A2FE-377BD35FB156Q45305297-3CA36BD3-D6E4-41CA-87CD-FEDA5B266B0DQ45857099-08414CE8-8A9D-4A16-8811-152B545474C1
P2860
Gene therapy for chronic myocardial ischemia using platelet-derived endothelial cell growth factor in dogs.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Gene therapy for chronic myoca ...... al cell growth factor in dogs.
@en
Gene therapy for chronic myoca ...... al cell growth factor in dogs.
@nl
type
label
Gene therapy for chronic myoca ...... al cell growth factor in dogs.
@en
Gene therapy for chronic myoca ...... al cell growth factor in dogs.
@nl
prefLabel
Gene therapy for chronic myoca ...... al cell growth factor in dogs.
@en
Gene therapy for chronic myoca ...... al cell growth factor in dogs.
@nl
P2093
P2860
P1476
Gene therapy for chronic myoca ...... al cell growth factor in dogs.
@en
P2093
Akio Ihaya
Kouichi Morioka
Kuniyoshi Tanaka
Masato Sasaki
Narihisa Yamada
Shinji Takamatsu
Takahiko Uesaka
Takeshi Tsuda
Tetsuya Kimura
P2860
P304
P356
10.1152/AJPHEART.00176.2004
P577
2004-09-16T00:00:00Z